Anavex Life Sciences Corp.

AVXL | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.40

-$0.02 (-0.83%)

At close: Sep 21, 2026, 4:00 PM ET

$2.43

+$0.03 (+1.25%)

Pre-market: Sep 22, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $224.27M

Enterprise Value $104.09M

Beta 1.14

Average Volume 1.1M

Shares Outstanding (Diluted) 91.45M

Shares Change YoY 7.11%

Institutional Ownership 43.15%

Exchange NASDAQ

ISIN US0327973006

Price Performance

Price Change 1M -25.2%

Price Change 3M -7.0%

Price Change 6M -12.4%

Price Change YTD -34.8%

Price Change 1Y -72.5%

Price Change 3Y -65.2%

Price Change 5Y -87.2%

1M CAGR (ann.) -26.2%

1Y CAGR (ann.) -72.4%

5Y CAGR (ann.) -33.6%

All-Time CAGR -7.0%

Valuation

PE Ratio -16.00

Forward PE 16.11

PEG Ratio -0.11

Forward PEG -0.14

PS Ratio N/A

Forward PS 0.20

PB Ratio 1.98

P/FCF Ratio -7.88

P/Adj. FCF Ratio -5.95

P/OCF Ratio -6.49

EV/Sales N/A

EV/EBIT -8.75

EV/EBITDA -8.75

EV/FCF -3.69

Earnings Yield -6.3%

FCF Yield -12.7%

Adj. FCF Yield -16.8%

Financial Health

Net Cash $118.33M

Total Debt $0

Cash & Short-Term Investments $118.33M

Total Assets $120.14M

Current Ratio 15.62

Quick Ratio 15.62

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 13.80

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -32.4%

Returns

Return on Assets -20.0%

Return on Equity -21.1%

Return on Invested Capital -27.3%

Return on Capital Employed -27.3%

Return on Tangible Assets -20.0%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 43.0%

EPS CAGR 5Y 19.8%

EPS CAGR 10Y 0.6%

FCF CAGR 3Y 7.1%

FCF CAGR 5Y -1.5%

FCF CAGR 10Y -11.2%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 13

EPS Growth Next 3Y 1068.9%

Revenue Growth Next 3Y N/A

Earnings Date Nov 23, 2026

EPS Estimate (next Q) -$0.11

EPS Growth Est (next Q) 0.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $11

Price Target Upside 358.3%

Cash Flow

Operating Cash Flow $-28.22M

Free Cash Flow $-28.22M

Adj. Free Cash Flow $-37.37M

FCF Per Share -$0.37

OCF Per Share -$0.37

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-17.37M

EBITDA $-11.9M

Net Income $-12.99M

EPS (Diluted) -$0.15

Revenue / Employee N/A

Profit / Employee $-381.94K

Employees 34